Softwr

Healthcare · head to head

Figure 1 vs Paige

Figure 1 logo

Figure 1

Healthcare

Medical photography and knowledge sharing platform

From
Free
Rated
-
Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-

The short version

  • Only Figure 1 has a free tier, so it costs nothing to try first.
  • They diverge on capability: Figure 1 covers Case Sharing, Paige covers Paige Prostate Detect.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Figure 1 and Paige actually diverge.

Attributes where Figure 1 and Paige differ
AttributeFigure 1Paige
Starting priceFreeOn request
Pricing modelfreemiumquote
Free tierYesNo
PlatformsWeb, MobileWeb, Cloud, On-premise
Founded2011Unknown

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Figure 1

  • Case Sharing
  • Secure Messaging
  • Image Upload
  • Knowledge Discovery
  • CME Access
  • Collaboration
  • HIPAA Compliant
  • HIPAA

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

What people use each for

The jobs each tool is most often brought in to do.

Figure 1

  • Patient Carenot Paige
  • Medical Recordsnot Paige
  • Practice Managementnot Paige
  • Telehealthnot Paige

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Figure 1
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Figure 1
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Figure 1
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Figure 1

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Figure 1

Nothing recorded yet. See the Figure 1 review.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Pricing, plan by plan

Figure 1

Free
  • FreeFree
    • Access to cases
    • HIPAA-compliant
    • Secure sharing

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Which should you pick?

Choose Figure 1 if

  • You need case sharing.
  • You want to start without paying.
  • You work on Web, Mobile.
  • You also want secure messaging.

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.

Questions people ask

Is Figure 1 or Paige better?
Neither clearly leads. Figure 1 starts at Free and Paige at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Figure 1 or Paige?
Figure 1 has a free tier; the other does not. Paid plans start at Free for Figure 1 and On request for Paige.
Does Figure 1 or Paige run on more platforms?
Figure 1 runs on Web, Mobile. Paige runs on Web, Cloud, On-premise.
Can I use Figure 1 for free?
Yes. Figure 1 has a free tier, so you can try it without paying. Paige starts at On request.
What is Figure 1 best used for?
Figure 1 is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Paige is typically brought in for.
What can Figure 1 do that Paige cannot?
Figure 1 covers Case Sharing, Secure Messaging, Image Upload, Knowledge Discovery. Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

Other head to heads